Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2362.2%
Neutral1437.8%
Bearish00.0%
Jacobs Solutions Inc. · J · FY2025 Q2 · Calendar Q2 2025
Jacobs Maintains FY2025 Guidance as Backlog Reaches Record
The quarter supports a constructive but conditional operating thesis: record backlog and demand in water, life sciences, data centers, and infrastructure provide growth visibility, while legal, FX, procurement, and margin risks remain material.
Reported Before market openNYSEIndustrials
$16.51B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.41
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $3.00B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-5.7%
Event window
SPY move
-0.8%
Same window
Abnormal move
-4.8%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
+5.1%
Up to 20 sessions
JSPY benchmark
Ask FN2 about J FY2025 Q2
Transcript, numbers and history already loaded
What drove J's -5.7% move after FY2025 Q2 earnings?What changed in J's guidance and outlook in FY2025 Q2?Give me the bull and bear case for J after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, backlog rose from $21.8 billion to a record $22.2 billion, while management moved from raised guidance to maintained full-year guidance. The quarter also added a legal reserve and highlighted the final Amentum share distribution and debt reduction through an equity-for-debt transaction.
Guidance delta
Full-year guidance was maintained, including mid- to high-single-digit revenue growth and adjusted EBITDA margin expansion toward approximately 14%.
Key takeaways
- Backlog increased 20% to a record $22.2 billion, supporting future-revenue visibility.
- Adjusted EPS rose 22% despite a material legal reserve and FX headwinds.
- Demand was highlighted across water and environmental services, life sciences, data centers, and critical infrastructure.
Management priorities
- Continue pursuing water cybersecurity and PFAS-remediation contracts.
- Advance life-science, data-center, quantum-computing, airport, and other critical-infrastructure projects.
- Invest in PA Consulting and expand digital-service capabilities.
Follow J with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$141.08Current
$137Low
$160.05Average
$175High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| UBS | Buy | Buy | Maintain | Aug 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| Citigroup | Buy | Buy | Maintain | May 6, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 13, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Nov 21, 2025 |
| Barclays | Overweight | Overweight | Maintain | Oct 20, 2025 |
| Benchmark | Hold | Buy | Downgrade | Nov 20, 2024 |
| William Blair | Market Perform | Outperform | Downgrade | May 8, 2024 |
| Argus Research | Buy | Buy | Maintain | Mar 14, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 22, 2023 |
| Stifel | Buy | Buy | Maintain | Nov 21, 2023 |
| TD Cowen | Outperform | Outperform | Maintain | Aug 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 9, 2023 |
| Bernstein | Outperform | Outperform | Maintain | May 10, 2023 |
| DA Davidson | Buy | Buy | Maintain | Nov 26, 2019 |
| Bank of America | Buy | Buy | Maintain | Nov 26, 2019 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 28, 2019 |
| MKM Partners | Buy | Buy | Maintain | Nov 21, 2018 |
| Seaport Global | Buy | Buy | Maintain | Nov 15, 2018 |
| Vertical Research | Buy | Hold | Upgrade | May 9, 2018 |
| Macquarie | Neutral | Underperform | Upgrade | May 9, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Deutsche Bank | Buy | Hold | Upgrade | Mar 29, 2018 |
| Goldman Sachs | Neutral | Sell | Upgrade | Jan 31, 2018 |
| Jefferies | Hold | Buy | Downgrade | Dec 13, 2016 |
| Johnson Rice | Hold | Accumulate | Downgrade | Aug 11, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 14, 2016 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 12, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Apr 29, 2015 |
| CLSA | Outperform | Buy | Maintain | Apr 13, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Feb 2, 2015 |
| Stephens & Co. | Overweight | Overweight | Maintain | Dec 20, 2013 |
| GARP Research | Buy | Buy | Maintain | Mar 28, 2013 |
| Gilford Securities | Buy | Buy | Maintain | Jan 10, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $141.08. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| KeyBanc | Sangita Jain | $166 | $142 | +17.7% | Oct 15, 2026 |
| Truist Financial | Analyst unavailable | $160 | $138.22 | +13.4% | Oct 5, 2026 |
| KeyBanc | Sangita Jain | $168 | $143.76 | +19.1% | Sep 8, 2026 |
| UBS | Analyst unavailable | $167 | $146.66 | +18.4% | Aug 10, 2026 |
| Goldman Sachs | Adam Bubes | $170 | $144.03 | +20.5% | Aug 6, 2026 |
| Truist Financial | Jamie Cook | $161 | $146.4 | +14.1% | Aug 5, 2026 |
| Robert W. Baird | Analyst unavailable | $153 | $142.68 | +8.4% | Aug 5, 2026 |
| RBC Capital | Analyst unavailable | $174 | $142.68 | +23.3% | Aug 5, 2026 |
| Truist Financial | Jamie Cook | $149 | $124.63 | +5.6% | Jul 2, 2026 |
| Bernstein | Chad Dillard | $163 | $124.12 | +15.5% | Jun 11, 2026 |
| RBC Capital | Sabahat Khan | $169 | $124.75 | +19.8% | May 6, 2026 |
| KeyBanc | Sangita Jain | $150 | $136.74 | +6.3% | May 6, 2026 |
| Goldman Sachs | Adam Bubes | $163 | $143.33 | +15.5% | Feb 4, 2026 |
| UBS | Steven Fisher | $175 | $137.42 | +24.0% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $160 | $137.85 | +13.4% | Feb 4, 2026 |
| Robert W. Baird | Andrew Wittmann | $143 | $132.91 | +1.4% | Feb 4, 2026 |
| Wells Fargo | Analyst unavailable | $137 | $140.09 | -2.9% | Jan 23, 2026 |
| KeyBanc | Analyst unavailable | $154 | $137.67 | +9.2% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $158 | $128.77 | +12.0% | Nov 24, 2025 |
| Truist Financial | Analyst unavailable | $152 | $129.17 | +7.7% | Nov 21, 2025 |
| RBC Capital | Analyst unavailable | $156 | $128.06 | +10.6% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $130 | $129.17 | -7.9% | Nov 21, 2025 |
| Robert W. Baird | Analyst unavailable | $146 | $129.17 | +3.5% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $160 | $153.2 | +13.4% | Nov 13, 2025 |
| Barclays | Adam Seiden | $160 | $155.39 | +13.4% | Oct 20, 2025 |
| KeyBanc | Analyst unavailable | $170 | $155.39 | +20.5% | Oct 20, 2025 |
| Truist Financial | Analyst unavailable | $163 | $155.31 | +15.5% | Oct 8, 2025 |
| Robert W. Baird | Andrew Wittmann | $161 | $148.48 | +14.1% | Aug 27, 2025 |
| Citigroup | Andrew Kaplowitz | $166 | $143.54 | +17.7% | Oct 22, 2024 |
| Raymond James | Brian Gesuale | $160 | $138.91 | +13.4% | Oct 4, 2024 |
| Stifel Nicolaus | Bert Subin | $160 | $149.71 | +13.4% | Apr 2, 2024 |
| Truist Financial | Jamie Cook | $154 | $150.64 | +9.2% | Mar 13, 2024 |
| RBC Capital | Analyst unavailable | $155 | $127.91 | +9.9% | Aug 4, 2022 |
| Citigroup | Analyst unavailable | $151 | $129.52 | +7.0% | Aug 2, 2022 |
| Credit Suisse | Analyst unavailable | $154 | $129.52 | +9.2% | Aug 2, 2022 |
| Stifel Nicolaus | Bert Subin | $158 | $124.36 | +12.0% | Jun 29, 2022 |
| Citigroup | Andrew Kaplowitz | $163 | $127.74 | +15.5% | Feb 9, 2022 |
Track every rating change on J the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationJacobs Solutions Inc. engages in the infrastructure and advanced facilities, and consulting businesses in the United States, Europe, Canada, India, Asia, Australia, New Zealand, the Middle East, and Africa. The company provides consulting, planning, architecture, design, engineering, and infrastructure delivery services including project, program, and construction management and long-term operation of facilities. It also offers consulting services for consumer and manufacturing, defense and security, energy and utilities, financial services, government, health and life sciences, and transport sectors. The company was founded in 1947 and is headquartered in Dallas, Texas.
Historical context
All J earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the J recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-22T00:02:47.536505+00:00
- Polygon adjusted daily market bars · 2026-10-17T09:40:42.473436+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T09:40:42.470533+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.